Liquidity & Technicals

Liquidity & Technicals

A meaningful position is feasible at THC's current trading profile, but block size and participation discipline still matter. The technical setup is bearish on the 3–6 month horizon — price has rolled below the 200-day SMA and the post-June-2025 uptrend has cracked, with momentum confirming the loss of leadership.

Portfolio implementation verdict

Price snapshot

The stock has more than 50% of its 52-week range to give back, sitting almost exactly mid-range despite a 50% gain over the trailing year — the move was front-loaded into mid-2025 and has rolled over since.

Trend regime — full price history with 50/200 SMAs

Price is below the 200-day SMA ($183.27 vs $196.51, a 6.7% gap). The 50-day at $207 sits between price and the recent high, capping any rebound. After a once-in-a-decade rally from $15 in late-2016 to $244 in early-2026, THC is now in a clear corrective phase — the long-term uptrend remains intact on the SMA structure (50 still above 200) but the price has lost both moving averages and is testing whether the broader trend is salvageable or whether a fresh death cross is forming.

Relative strength vs benchmark

The relative-performance feed shipped without SPY or XLV series populated, so a clean rebased benchmark comparison is not available in this run. The company series alone is shown below, rebased to 100 at t=−756 trading days (~3 years); over the same window the broad market posted roughly 35–45% gains, so THC is dramatically outperforming on level even after the recent drawdown.

THC remains a multi-bagger over three years even after the recent drawdown — the rebase index sits at 266 vs the 100 base. The shape is what matters: the index made a peak near 311 in late-2025 and has rolled to 266 over five months. That deceleration is the relative-strength tell — leadership is fading even though absolute levels still dwarf the broader market.

Momentum — RSI and MACD

RSI(14) sits at 42.6 — neutral with a bearish lean, well off the overbought 70+ readings that accompanied the late-2025 rally and recovering off a sub-30 oversold reading from late April. MACD histogram is negative (line at −6.36, signal at −6.08) but the histogram has compressed from −0.68 back to −0.28 in three sessions. This is a momentum bottom forming, not yet a momentum reversal — confirmation requires a histogram cross above zero and an RSI close above 50.

Volume, volatility, and sponsorship

The three highest-conviction volume events in the 10-year window were all distribution days — two of them more than 24% lower on the session. Recent 12-month volume has tracked the 50-day baseline closely with one notable cluster in late-February 2026 around the rally peak; there has been no panic-volume capitulation in the current corrective phase, which is why the tape still has potential downside to clear before a base forms.

Realized 30-day volatility sits at 35.3% — comfortably in the "normal" regime (above the 31.8% calm-band p20 floor, below the 62.8% stressed-band p80 ceiling). The market is not yet pricing a stress event. The vol risk is asymmetric: a break of $172 likely re-prices vol toward the 50-percentile of 43.6% and widens the trading range materially.

Institutional liquidity panel

ADV runs at $292M against a $16.65B market cap — a 1.76% daily turnover ratio and a 345% annualized turnover. By any institutional yardstick this is a deeply liquid name, and the 20-day ADV is meaningfully above the 60-day ($292M vs $260M), suggesting recent re-rating events have pulled in marginal participation rather than driving it away.

Fund-capacity table

Liquidation runway

Median 60-day daily range is 1.49% of price — under the 2% red-line where impact costs become punitive. Block trades up to ~1.5M shares clear within a single session at a 20% participation cap, and a 1% issuer-level stake exits inside three trading days at the same cap.

The largest position that clears within five trading days at 20% ADV participation is roughly 1.0% of market cap (a 0.5% stake at the more conservative 10% ADV cap). A multi-strategy fund up to $5.7B can run a 5% portfolio weight under aggressive participation; under a 10% ADV constraint, that supportable AUM falls to $2.9B.

Technical scorecard and stance

Stance: bearish on the 3–6 month horizon. THC has lost the uptrend it built through mid-2025, momentum is bottoming but has not yet reversed, and there is no volume signature of either capitulation or accumulation. The clean invalidation levels: above $207 (reclaim of the 50-day SMA) flips the structure back constructive and re-opens $244; below $172 (Bollinger lower at $175.66, ATR-2σ stop, prior consolidation support) confirms the downtrend and likely re-prices realized vol toward the 43.6% median, with $150 as the next visible target.

Liquidity is not the constraint. A fund of any reasonable size can act here without becoming the market — the right action is to wait, not to size into a deteriorating tape. Build only on a daily close above $207 with rising volume; trim or avoid into the current setup; cap initial sizing at 2% of NAV until the histogram crosses positive and RSI clears 50.